No linked studies yet.
Omega-3 Triglyceride Fish Oil 1100 mg
Product analysis
Omega-3 Triglyceride Fish Oil 1100 mg supplies EPA and DHA, with its clearest support relating to blood fat balance. It offers good value for combined omega-3 intake, though it is less economical if DHA is your main priority.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The ingredient-form descriptions are incomplete, limiting a confident quality comparison. Clear active-fat amounts do not by themselves settle the quality of the oil or its forms.
Ingredient Transparency70
The amounts and relevant composition details are disclosed, making the active fats easier to compare. Form descriptions are incomplete, so that part of the label is less informative.
Value For Money75
The combined EPA and DHA offer good value, with EPA also comparing favorably on cost. DHA alone is relatively expensive, so value depends on which active fats you want.
Customer Satisfaction89
Customer ratings are very positive across a large number of buyers. The breadth of feedback makes the satisfaction picture more dependable without proving a health benefit.
Product Focus68
The clearest connection is to blood fat balance, while the many other proposed uses have more mixed or conditional support. The active EPA and DHA amounts are more useful for judging that purpose than total oil weight.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.49
- Also available
Omega-3 Triglyceride Fish Oil 1100 mg$44.95- Customer rating
- 4.8 · 2,951 ratings
Goals
EPA provides the main connection to triglyceride-related support, while DHA has limited lipid and vascular-surrogate evidence. Their declared amounts are considered as alternatives in the saved result, without adding their contributions or assuming synergy. The 729 mg EPA serving receives partial amount recognition. These findings do not transfer prescription EPA outcomes or establish routine cardiovascular-event prevention.
How this product is rated for Heart Health
Ingredient fit78
Goal fit
Dose adequacy
Pathways58
Depth
Breadth
Evidence100
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
EPA and DHA provide the main connection through triglyceride metabolism. Their declared active amounts contribute separately; total oil weight does not establish the same exposure. Supporting studies concern blood markers in specific populations and do not establish prevention of cardiovascular events.
How this product is rated for Cardiovascular Support
Ingredient fit76
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence83
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
EPA and DHA are marine fats that may lower some markers of inflammation. That offers a possible benefit for this goal, although a change in blood markers doesn't necessarily mean noticeable symptom relief. The separately declared EPA and DHA amounts describe the active fats more usefully than total fish-oil weight; a broad, reliable clinical benefit remains uncertain.
How this product is rated for Inflammation
Ingredient fit65
Goal fit
Dose adequacy
Pathways15
Depth
Breadth
Evidence70
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
DHA is a structural component of the retina, and fish oil supplies both DHA and EPA. That structural role does not establish improved vision from routine supplementation. Trials of EPA and DHA did not show an overall added benefit for age-related macular degeneration or an advantage over placebo for moderate-to-severe dry eye.
How this product is rated for Eye Health
Ingredient fit77
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence79
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
No linked studies yet.
Whether omega-3 makes your body burn more calories is unclear for adults generally. Its possible effects on resting energy use vary across groups of people, so the amount in a serving can't predict a metabolism boost for you. That uncertainty also prevents a promise of lasting weight or fat loss.
How this product is rated for Metabolism Support
Ingredient fit50
Goal fit
Dose adequacy
Pathways41
Depth
Breadth
Evidence89
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Omega-3 fatty acids, including EPA and DHA, may provide small improvements in joint pain, stiffness or function in some inflammatory-joint and osteoarthritis settings. Findings are mixed, with important large trials showing no benefit. The evidence concerns sustained study regimens, so a label serving does not establish the same exposure or outcome, and it does not show cartilage repair or prevention. The 275 mg DHA per serving falls below the saved substantial-contribution threshold.
How this product is rated for Joint Health
Ingredient fit74
Goal fit
Dose adequacy
Pathways17
Depth
Breadth
Evidence69
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 15 Calorie(s) | |
Calories from Fat | 10 Calorie(s) | |
Total Fat | 1.5 Gram(s) | |
Molecularly distilled Fish Oil | 1326 mg | |
Total Omega-3 Fatty Acids | 1100 mg | |
Eicosapentaenoic Acid | 729 mg | |
Docosahexaenoic Acid | 275 mg | |
Other Omega-3 Fatty Acids | 86 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability83
Molecular Form and Bioavailability
EPA Concentration Density
Oxidation Protection
Dose, Safety & Label Transparency82
Absolute EPA Dose per Serving
EPA-Centric Ratio
Purity and Contaminant Testing
Value80
Price per Gram of EPA
How this ingredient is rated
Active Ingredient Quality & Bioavailability74
Omega-3 Molecular Form
Purification & Filtration Method
Third-Party Purity & Potency Verification
Source & Sustainability
Dose, Safety & Label Transparency94
Total Active Omega-3 Dose (EPA + DHA)
Omega-3 Potency & Concentration
EPA & DHA Individual Disclosure
Oxidation Protection (Stabilizers)
Value80
Cost Per Gram of Active EPA + DHA
How this ingredient is rated
Active Ingredient Quality & Bioavailability72
Molecular Form & Absorption Potential
Source Purity & Oxidative Protection
Dose, Safety & Label Transparency73
EPA & DHA Label Specificity
Active Ingredient Concentration
Third-Party Purity Verification
Value100
Price per 1000mg of EPA+DHA
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
- Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
- Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
- Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
- Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.